Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Firas Fneish"'
Autor:
Niklas Frahm, David Ellenberger, Alexander Stahmann, Firas Fneish, Daniel Lüftenegger, Hans C. Salmen, Ksenija Schirduan, Tom P. A. Schaak, Peter Flachenecker, Christoph Kleinschnitz, Friedemann Paul, Dagmar Krefting, Uwe K. Zettl, Melanie Peters, Clemens Warnke
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: The spectrum of disease-modifying therapies (DMTs) for people with multiple sclerosis (PwMS) has expanded over years, but data on treatment strategies is largely lacking. DMT switches are common clinical practice. Objective: To compare sw
Externí odkaz:
https://doaj.org/article/c8eeaeea69924efc9284aba8da3cbdca
Autor:
Alexander Stahmann, Elaine Craig, David Ellenberger, Firas Fneish, Niklas Frahm, Ruth Ann Marrie, Rod Middleton, Richard Nicholas, Jeff Rodgers, Clemens Warnke, Amber Salter
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 17 (2024)
Background: Treatment guidelines recommend early disease-modifying therapy (DMT) initiation after diagnosis of multiple sclerosis (MS). Multinational comparative studies that assess time to DMT initiation in MS may allow detection of barriers inheren
Externí odkaz:
https://doaj.org/article/85e9dcff225c45649ad0ca9d2536773d
Autor:
Firas Fneish, Niklas Frahm, Melanie Peters, David Ellenberger, Judith Haas, Micha Löbermann, Dieter Pöhlau, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Friedemann Paul, Uwe K. Zettl
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1859 (2023)
Several studies reported post-SARS-CoV-2-vaccination (PV) symptoms. Even people with multiple sclerosis (PwMS) have concerns about disease activity following the SARS-CoV-2 vaccination. We aimed to determine the proportion of PwMS with PV relapses, t
Externí odkaz:
https://doaj.org/article/fd7179958544494b9322499460d272e4
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Judith Haas, Micha Loebermann, Tina Parciak, Melanie Peters, Dieter Pöhlau, Jeff Rodgers, Anna-Lena Röper, Sarah Schilling, Alexander Stahmann, Herbert Temmes, Uwe K. Zettl, Rodden M. Middleton
Publikováno v:
The Lancet Regional Health. Europe, Vol 22, Iss , Pp 100502- (2022)
Summary: Background: Vaccines offer people with multiple sclerosis (PwMS) an effective protection against severe COVID-19 disease courses. However, representative real-world data on the tolerability of SARS-CoV-2 vaccines in PwMS are limited. We aime
Externí odkaz:
https://doaj.org/article/9a6b3486974f4051a56463f363e21125
Autor:
Vanessa Strüver, BA, MSc, Sheraz Ali, PharmD, PhD Sch, MPH, Firas Fneish, MSc, Gerhard Fortwengel, BSc, MPH, PhD
Publikováno v:
Current Therapeutic Research, Vol 96, Iss , Pp 100656- (2022)
ABSTRACT: Background: The globalization of clinical research should also benefit the population in developing markets. In this context, the approval of tested medicines and the associated expansion of medical care beyond clinical studies would be des
Externí odkaz:
https://doaj.org/article/fb19ffb876f740dd876519e023f490ef
Publikováno v:
Current Therapeutic Research, Vol 95, Iss , Pp 100643- (2021)
ABSTRACT: Regulatory authorities have encouraged the usage of a risk-based monitoring (RBM) system in clinical trials before trial initiation for detection of potential risks and inclusion of a mitigation plan in the monitoring strategy. Several RBM
Externí odkaz:
https://doaj.org/article/16a288bef9964419a300e6b003e1feb3
Autor:
Paulus S. Rommer, Klaus Berger, David Ellenberger, Firas Fneish, Alexandra Simbrich, Alexander Stahmann, Uwe K. Zettl
Publikováno v:
Frontiers in Neurology, Vol 11 (2020)
Daclizumab was approved by the FDA and the EMA in 2016 for the treatment of relapsing forms of multiple sclerosis (MS). Cases of severe inflammatory brain disease with fatal outcome led to the withdrawal of approval in Europe and the US on March 2, 2
Externí odkaz:
https://doaj.org/article/e6c33d9b2b4b49d19dcdf78faaefe9d2
Autor:
Sam Chidi Ibeneme, Gerhard Fortwengel, Ifeoma Joy Okoye, Wilfred Okwudili Okenwa, Amarachi Destiny Ezuma, Akachukwu Omumuagwula Nwosu, Georgian Chiaka Ibeneme, Amaka Nnamani, Dnyanesh Limaye, Firas Fneish, Hellen Myezwa, Okere Philip, Nneka Iloanusi, Adedayo Tunde Ajidahun, Ifeoma Ulasi
Background Bone demineralization in people living with HIV (PLWH) could be ameliorated by biomechanical loading of the musculoskeletal system which exerts an osteogenic stimulus. Therefore, we determined whether the bone mineral density (BMD) varied
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ad1db7272b8a5779021f4f4a4a78e61
https://doi.org/10.21203/rs.3.rs-2656062/v1
https://doi.org/10.21203/rs.3.rs-2656062/v1
Autor:
Niklas Frahm, Firas Fneish, David Ellenberger, Melanie Peters, Herbert Temmes, Alexander Stahmann
Publikováno v:
NeuroTransmitter. 33:40-44
Autor:
Dwi Aris Agung Nugrahaningsih, Firas Fneish, Christantie Effendy, Mae Sri Hartati Wahyuningsih, Gerhard Fortwengel, Andina Setyawati
Publikováno v:
Saudi Journal of Biological Sciences
Saudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 7257-7268 (2021)
Saudi Journal of Biological Sciences, Vol 28, Iss 12, Pp 7257-7268 (2021)
Graphical abstract
Highlights • The most active fraction of Piper crocatum Ruiz & Pav (FIV), originated from methanol extracts and wash benzene-soluble extracts, has diabetic wound healing activities on wounded hyperglycemia fibroblasts. • F
Highlights • The most active fraction of Piper crocatum Ruiz & Pav (FIV), originated from methanol extracts and wash benzene-soluble extracts, has diabetic wound healing activities on wounded hyperglycemia fibroblasts. • F